已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Beinaglutide for weight management in Chinese individuals with overweight or obesity: A phase 3 randomized controlled clinical study

医学 安慰剂 超重 优势比 体质指数 内科学 腰围 肥胖 减肥 置信区间 随机对照试验 不利影响 恶心 胃肠病学 替代医学 病理
作者
Kang Chen,Li Chen,Zhongyan Shan,Guixia Wang,Shen Qu,Guijun Qin,Xuefeng Yu,Weiquan Xin,Tsung‐han Hsieh,Yiming Mu
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
卷期号:26 (2): 690-698 被引量:12
标识
DOI:10.1111/dom.15360
摘要

Abstract Aim To investigate the efficacy and safety of beinaglutide as an adjunct to lifestyle intervention among non‐diabetic Chinese individuals with overweight or obesity. Methods This multicentre, randomized, double‐blind, placebo‐controlled trial (ChiCTR1900023428) included 427 Chinese adults with a body mass index of 28 kg/m 2 or higher (obesity) or 24‐27.9 kg/m 2 (overweight) with weight‐related complications. Patients were randomized in a 2:1 ratio to receive 0.2 mg of beinaglutide (subcutaneous) thrice daily or placebo for 16 weeks. Co‐primary endpoints were body weight change and the proportion of patients with a weight reduction of 5% or more. Results Mean body weight change from baseline to week 16 was −6.0% and −2.4% in the beinaglutide ( n = 282) and placebo ( n = 138) groups, respectively; the mixed model repeated measures difference was −3.6% (95% confidence interval: −4.6% to −2.6%; P < .0001). At week 16, more beinaglutide‐treated patients achieved a weight reduction of 5% or more (58.2% vs. 25.4% [placebo], odds ratio: 4.4; P < .0001) and of 10% or more (21.3% vs. 5.1% [placebo], odds ratio: 5.5; P < .0001). Beinaglutide also resulted in greater waist circumference reduction (difference: −1.81 cm; P < .01). The weight regain rate 12 weeks after beinaglutide treatment was 0.78%. Nausea (transient and mild‐to‐moderate) was the most common adverse event in the beinaglutide group (49.3% vs. 7.1% [placebo]). More patients receiving beinaglutide discontinued treatment because of adverse events (5.9% vs. 0.7% [placebo]). Pancreatitis or an increased resting heart rate was not observed in the beinaglutide group. Conclusion Beinaglutide combined with lifestyle intervention resulted in significant and clinically meaningful weight reduction with good tolerance in non‐diabetic Chinese individuals with overweight or obesity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
3秒前
tt发布了新的文献求助10
4秒前
酷波er应助momo采纳,获得10
4秒前
4秒前
5秒前
搞怪熊猫完成签到,获得积分10
8秒前
简约生活完成签到,获得积分10
10秒前
Accelerator完成签到,获得积分10
10秒前
漂亮白枫发布了新的文献求助10
10秒前
11秒前
威廉兰尼斯特完成签到,获得积分10
11秒前
FashionBoy应助Arui采纳,获得10
14秒前
李健应助tt采纳,获得10
16秒前
呆萌安双完成签到 ,获得积分10
17秒前
Ray发布了新的文献求助10
17秒前
CipherSage应助大面包采纳,获得10
20秒前
L.C.完成签到,获得积分10
21秒前
大个应助漂亮白枫采纳,获得10
22秒前
23秒前
23秒前
万能图书馆应助dapis采纳,获得10
24秒前
25秒前
26秒前
恋雅颖月应助miles采纳,获得10
27秒前
27秒前
岂曰无衣完成签到 ,获得积分10
27秒前
大模型应助victoria采纳,获得10
29秒前
大头发布了新的文献求助10
31秒前
31秒前
赵杰发布了新的文献求助10
32秒前
33秒前
予秋发布了新的文献求助10
33秒前
momo发布了新的文献求助10
33秒前
我是老大应助瘦瘦语蕊采纳,获得10
37秒前
大面包发布了新的文献求助10
37秒前
39秒前
QTQ发布了新的文献求助10
39秒前
40秒前
怕黑大白菜真实的钥匙完成签到,获得积分10
40秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989857
求助须知:如何正确求助?哪些是违规求助? 3531994
关于积分的说明 11255679
捐赠科研通 3270758
什么是DOI,文献DOI怎么找? 1805053
邀请新用户注册赠送积分活动 882195
科研通“疑难数据库(出版商)”最低求助积分说明 809208